Case report: Paralytic ileus resulted from nirmatrelvir/ritonavir-tacrolimus drug-drug interaction in a systemic lupus erythematosus patient with COVID-19

• Main Authors: Wei Zhang (Author), Xingguo Zhang (Author), Jinming Han (Author), Wen Zhang (Author), Jiarui Xu (Author), Xin Zhang (Author), Hongjun Bian (Author), Chong Meng (Author), Deya Shang (Author), Yi Zhou (Author), Dawei Wang (Author), Baobao Feng (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Patients with systemic autoimmune rheumatic diseases are at a high risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and effective antiviral treatments including nirmatrelvir/ritonavir can improve their outcomes. However, there might be potential drug-drug interactions...